Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Experts agree: HFmrEF should not be ignored | Cardiologist makes 'Magic' with new device | When bioprosthetic mitral valves fail

News You Need to Know Today
Experts agree: HFmrEF should not be ignored | Cardiologist makes 'Magic' with new device | When bioprosthetic mitral valves fail
Thursday, April 23, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Heart failure experts agree: HFmrEF should not be ignored

Data on the treatment and management of HFmrEF are limited, but a new scientific statement from the Heart Failure Society of America highlights how important it is to take this condition seriously.

READ MORE >
doctor patient elderly check up hospital
Share on Twitter Share on Facebook Share on Linkedin

Heart failure experts agree: HFmrEF should not be ignored

Share on Twitter Share on Facebook Share on Linkedin
doctor patient elderly check up hospital
Data on the treatment and management of HFmrEF are limited, but a new scientific statement from the Heart Failure Society of America highlights how important it is to take this condition seriously.
READ MORE >

Cardiologist makes ‘Magic,’ performs first procedure in US with new-look ablation catheter

Users guide the robotically navigated catheter using computer-controlled magnetic fields. It gained FDA approval in January.

READ MORE >
Nathan McConkey, DO, MPH, an electrophysiologist with Oregon Health & Science University (OHSU), made history when he used the Magic Magnetic Interventional Ablation Catheter.
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist makes ‘Magic,’ performs first procedure in US with new-look ablation catheter

Share on Twitter Share on Facebook Share on Linkedin
Nathan McConkey, DO, MPH, an electrophysiologist with Oregon Health & Science University (OHSU), made history when he used the Magic Magnetic Interventional Ablation Catheter.
Users guide the robotically navigated catheter using computer-controlled magnetic fields. It gained FDA approval in January.
READ MORE >

When bioprosthetic mitral valves fail: Redo surgery bests transcatheter treatment after 5 years

Short-term outcomes were comparable, but long-term data revealed a significant difference in all-cause mortality.

READ MORE >
Tiny fragments of plastic are commonly found deep inside the human body. Heart surgery, it seems, is one of many ways these microplastics are reaching their destination.  Surgeons Operating On Patient
Share on Twitter Share on Facebook Share on Linkedin

When bioprosthetic mitral valves fail: Redo surgery bests transcatheter treatment after 5 years

Share on Twitter Share on Facebook Share on Linkedin
Tiny fragments of plastic are commonly found deep inside the human body. Heart surgery, it seems, is one of many ways these microplastics are reaching their destination.  Surgeons Operating On Patient
Short-term outcomes were comparable, but long-term data revealed a significant difference in all-cause mortality.
READ MORE >

Featured Articles

How to prevent the most common complication after heart surgery

The Society of Thoracic Surgeons put together an expert committee to examine the prevention and treatment of new-onset postoperative atrial fibrillation after cardiac surgery. The group shared recommendations for before, during and after treatment.

READ MORE >
Compensation for U.S. cardiologists is up across the board, according to a recent survey published by MedAxiom, an American College of Cardiology company. The report identified similar trends for cardiovascular surgeons, highlighting the country’s high demand for all heart specialists in 2024 and beyond.
Share on Twitter Share on Facebook Share on Linkedin

How to prevent the most common complication after heart surgery

Share on Twitter Share on Facebook Share on Linkedin
Compensation for U.S. cardiologists is up across the board, according to a recent survey published by MedAxiom, an American College of Cardiology company. The report identified similar trends for cardiovascular surgeons, highlighting the country’s high demand for all heart specialists in 2024 and beyond.
The Society of Thoracic Surgeons put together an expert committee to examine the prevention and treatment of new-onset postoperative atrial fibrillation after cardiac surgery. The group shared recommendations for before, during and after treatment.
READ MORE >

Evolocumab reduces risk of major cardiac events in diabetic patients

Late-breaking data out of ACC.26 suggest a more aggressive treatment approach for these patients could be beneficial. 

READ MORE >
Nicholas Marston, MD, MPH assistant professor of medicine, and a cardiologist at Brigham and Women's Hospital, presented the late-breaking VESALIUS-CV data on the use of evolocumab for the reduction of major cardiovascular events in patients who do not have significant atherosclerosis. #ACC26
Share on Twitter Share on Facebook Share on Linkedin

Evolocumab reduces risk of major cardiac events in diabetic patients

Share on Twitter Share on Facebook Share on Linkedin
Nicholas Marston, MD, MPH assistant professor of medicine, and a cardiologist at Brigham and Women's Hospital, presented the late-breaking VESALIUS-CV data on the use of evolocumab for the reduction of major cardiovascular events in patients who do not have significant atherosclerosis. #ACC26
Late-breaking data out of ACC.26 suggest a more aggressive treatment approach for these patients could be beneficial. 
READ MORE >

Medtronic leads $100M investment in artery denervation company

Pulnovo Medical, a global medtech company, plans on using the funds for clinical development, regulatory submissions, commercialization and much more. 

READ MORE >
pulmonary hypertension denervation pulnovo medical
Share on Twitter Share on Facebook Share on Linkedin

Medtronic leads $100M investment in artery denervation company

Share on Twitter Share on Facebook Share on Linkedin
pulmonary hypertension denervation pulnovo medical
Pulnovo Medical, a global medtech company, plans on using the funds for clinical development, regulatory submissions, commercialization and much more. 
READ MORE >

Sirolimus- and paclitaxel-coated balloons deliver comparable 1-year PCI outcomes

Researchers explored data from more than 8,000 patients treated over a three-year period. 

READ MORE >
Illustration of cardiologists going through the certification process. American College of Cardiology President B. Hadley Wilson, MD, discussed why the ACC and other leading cardiology groups are so eager to create a new, independent medical board. This has been a long-term goal for many years, he said, and now it may become a reality. 
Share on Twitter Share on Facebook Share on Linkedin

Sirolimus- and paclitaxel-coated balloons deliver comparable 1-year PCI outcomes

Share on Twitter Share on Facebook Share on Linkedin
Illustration of cardiologists going through the certification process. American College of Cardiology President B. Hadley Wilson, MD, discussed why the ACC and other leading cardiology groups are so eager to create a new, independent medical board. This has been a long-term goal for many years, he said, and now it may become a reality. 
Researchers explored data from more than 8,000 patients treated over a three-year period. 
READ MORE >

In Case You Missed It

‘Practice-changing’ interventional cardiology research grabs ACC.26 spotlight

The second day of the American College of Cardiology’s annual conference started with a series of highly anticipated interventional cardiology trials.

READ MORE >
Divaka Perera, MD, at ACC.26
Share on Twitter Share on Facebook Share on Linkedin

‘Practice-changing’ interventional cardiology research grabs ACC.26 spotlight

Share on Twitter Share on Facebook Share on Linkedin
Divaka Perera, MD, at ACC.26
The second day of the American College of Cardiology’s annual conference started with a series of highly anticipated interventional cardiology trials.
READ MORE >

FDA clears new AI model for pulmonary hypertension

The advanced algorithm, which previously received the FDA's breakthrough device designation, detects signs of pulmonary hypertension in standard 12-lead electrocardiograms.

READ MORE >
AI model algorithm tablet digital patient data
Share on Twitter Share on Facebook Share on Linkedin

FDA clears new AI model for pulmonary hypertension

Share on Twitter Share on Facebook Share on Linkedin
AI model algorithm tablet digital patient data
The advanced algorithm, which previously received the FDA's breakthrough device designation, detects signs of pulmonary hypertension in standard 12-lead electrocardiograms.
READ MORE >

Catheter-based treatment linked to major benefits for intermediate-risk PE

New 30-day data presented at ACC.26 helped answer questions cardiologists have had been asking for years. “Thank you for bringing PE into the future," one vascular specialist said from the stage.  

READ MORE >
 Stavros V. Konstantinides, MD, PhD, presenting data at ACC.26
Share on Twitter Share on Facebook Share on Linkedin

Catheter-based treatment linked to major benefits for intermediate-risk PE

Share on Twitter Share on Facebook Share on Linkedin
 Stavros V. Konstantinides, MD, PhD, presenting data at ACC.26
New 30-day data presented at ACC.26 helped answer questions cardiologists have had been asking for years. “Thank you for bringing PE into the future," one vascular specialist said from the stage.  
READ MORE >

In Other News

Middle-aged Americans who exercise now will enjoy longer, healthier lives later

The more you maintain good physical fitness from your mid-40s to your mid-60s, the likelier you are to add years to your life and life to your later years. 

READ MORE >
exercise workout senior
Share on Twitter Share on Facebook Share on Linkedin

Middle-aged Americans who exercise now will enjoy longer, healthier lives later

Share on Twitter Share on Facebook Share on Linkedin
exercise workout senior
The more you maintain good physical fitness from your mid-40s to your mid-60s, the likelier you are to add years to your life and life to your later years. 
READ MORE >

UnitedHealthcare drops most prior authorizations in rural areas as part of improvement initiative

The insurance giant has been piloting a program to speed up reimbursement to hospitals in 10 states, reducing delays by roughly 50%. Now, the company said it will work to lift prior authorization barriers on patient care delivery. The intent is to roll out these changes nationwide by the end of 2026, UnitedHealthcare confirmed.

READ MORE >
rural_road.jpg
Share on Twitter Share on Facebook Share on Linkedin

UnitedHealthcare drops most prior authorizations in rural areas as part of improvement initiative

Share on Twitter Share on Facebook Share on Linkedin
rural_road.jpg
The insurance giant has been piloting a program to speed up reimbursement to hospitals in 10 states, reducing delays by roughly 50%. Now, the company said it will work to lift prior authorization barriers on patient care delivery. The intent is to roll out these changes nationwide by the end of 2026, UnitedHealthcare confirmed.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Strokes after PFA | Hospital sues practice | FDA approves fast-acting drug for children | The cardiologist shortage continues
CMS & FDA propose major Medicare changes | Big news for Biotronik | New imaging data on MINOCA | The first procedure of its kind
News Alert: Trump administration moves to speed up Medicare coverage for breakthrough devices
Experts agree: HFmrEF should not be ignored | Cardiologist makes 'Magic' with new device | When bioprosthetic mitral valves fail
A new warning for cath labs | The push for better safety standards | Major recalls | FDA clears next-gen imaging system
The most common complication after heart surgery | Evolocumab makes an impact | New DCB data | Medtronic leads $100M investment
Heart Rhythm 2026 | The cardiovascular safety of new weight loss pill | Rethinking PCI timing | FDA clears hybrid imaging system

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …5
    • Page 6
    • Page 7
    • Page 8
    • Current page 9
    • Page 10
    • Page 11
    • Page 12
    • Page 13 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup